Skip to main content
Log in

Outcome of breast-conserving therapy in the Tokyo women’s medical university breast cancer society experience

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

The results of BCT in Japanese women have not been fully evaluated. The Tokyo Women’s Medical University Breast Cancer Society initiated BCT protocols in 1987. Here, we present a retrospective analysis of BCT outcomes and identify prognostic factors.

Methods

The study population comprised 348 patients (353 breasts) with UICC clinical stage 0, I or II breast cancer, for whom wide excision (n = 294), quadrantectomy (n = 56) and tumorectomy (n = 3) were performed. The final pathological margin states were positive in 102 breasts (cancer cells remained within 5 mm of the surgical margin). The whole breast was irradiated to a total dose with 44 Gy/20 fractions or 46 Gy/23 fractions in the patients with negative surgical margins. The patients with positive or close margins received 48.4 Gy/22 fractions or 50 Gy/25 fractions irradiation to the whole breast. All but 2 patients received a radiation boost to the tumor bed and all tumor beds were irradiated to more than 53 Gy. Adjuvant therapy was administered in 240 cases. The median follow-up time was 4.3 years.

Results

The 5-year overall, cause-specific and disease-free survival rates were 95.8%, 97.3% and 92.5%, respectively. Recurrence was observed in 29 patients including 11 patients with loco-regional recurrence. Local recurrence was observed in 6 patients, 5 of whom were premenopausal. The 5-year local control and loco-regional control rates were 98.9% and 96.6%, respectively. T status (T1 to T2) was the only significant prognostic factor for disease-free survival. No severe morbidity has been observed. Cosmetic results were excellent or good in 73% of patients.

Conclusion

Our BCT protocols provide a high rate of local control and good cosmetic outcome. Pathologic margin status was not a major prognostic factor for local recurrence. Long term follow-up is required to reach a definite conclusion on optimal BCT protocols.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

BCT:

Breast-conserving therapy

UICC:

Union Internationale Contre 1e Cancer

ECOG:

Eastern Cooperative Oncology Group

ER:

Estrogen receptor

PgR:

Progesterone receptor

DCC:

Dextrancoated charcoal

EIA:

Enzyme immunoassay

LH-RH:

Luteinizing hormone-releasing hormone

LENT SOMA scale:

Late Effects Normal Tissues, Subjective, Objective, Management and Analysis scale

EORTC:

the European Organization for Research and Treatment of Cancer

We:

Wide excision

Bq:

Quadrantectomy

Tm:

Tumorectomy

inf:

Inflammatory type

Bp:

Partial mastectomy

WB:

Whole breast irradiation

LO:

Local boost irradiation

NSABP:

National Surgical Adjuvant Breast and Bowel Project

Osaka MCCCD:

Osaka Medical Center for Cancer and Cardiovascular Diseases

TWMU:

Tokyo Women’s Medical University

References

  1. van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K, Bartelink H: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.J Natl Cancer Inst 92:1143–1150, 2000.

    Article  PubMed  Google Scholar 

  2. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N: Twenty-year follow-up of a randomized clinical trial comparing total mastectomy, lumpectomy and lumpectomy with irradiation for the treatment of invasive breast cancer.N Engl J Med 347:1233–1241, 2002.

    Article  PubMed  Google Scholar 

  3. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E: Twenty-year follow-up of a randomized study comparing breastconserving surgery with radical mastectomy for early breast cancer.N Engl J Med 347:1227–1232, 2002.

    Article  PubMed  Google Scholar 

  4. Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H, Adami HO: 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial.J Clin Oncol 17:2326–2333, 1999.

    PubMed  CAS  Google Scholar 

  5. Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, Lipa M, Wilkinson RH, Mahoney LJ: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group.J Natl Cancer Inst 88:1659–1664, 1996.

    Article  PubMed  CAS  Google Scholar 

  6. Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN, Smith DC, George WD: Randomized controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group.Lancet 348:708–713, 1996.

    Article  PubMed  CAS  Google Scholar 

  7. Romestaing P, Lehingue Y, Carrie C, Coquard R, Montbarbon X, Ardiet JM, Mamelle N, Gerard JP: Role of a 10-Gy boost in conservation treatment of early breast cancer: results of a randomized clinical trial in Lyon, France.J Clin Oncol 15:963–968, 1997.

    PubMed  CAS  Google Scholar 

  8. Kokubo M, Mitsumori M, Ishikura S, Nagata Y, Fujishiro S, Inamoto T, Mise K, Kodama H, Sasai K, Hiraoka M: Results of breast-conserving therapy for early stage breast cancer: Kyoto University experiences.Am J Clin Oncol 23:499–505, 2000.

    PubMed  CAS  Google Scholar 

  9. Kodaira T, Fuwa N, Itoh Y, Matsumoto A, Kamata M, Furutani K, Sasaoka M, Miura S, Takeuchi T: Aichi Cancer Center 10-year experience with conservative breast treatment of early breast cancer: retrospective analysis regarding failure patterns and factors influencing local control.Int J radiation Oncol Biol Phys 49:1311–1316, 2001.

    CAS  Google Scholar 

  10. Horiguchi J, Koibuchi Y, Takei H, Yokoe T, Yamakawa M, Nakajima T, Oyama T, lino Y, Morishita Y: Breast-conserving surgery following radiation therapy of 50 Gy in stages I and II carcinoma of the breast: the experience at one institute in Japan.Oncol Rep 9:1053–1057, 2002.

    PubMed  Google Scholar 

  11. Komoike Y, Motomura K, Inaji H, Kasugai T, Nose T, Koizumi M, Koyama H: Long-Term Results of Breast Conserving Surgery for Stages I and II Breast Cancer: Experiences at Osaka Medical Center for Cancer and Cardiovascular Diseases.Breast Cancer 9:248–253, 2002.

    Article  PubMed  Google Scholar 

  12. Koyama H, Inaji H, Noguchi S, Motomura K: Recent progress in breast conserving therapy: from experiences in Japan.Breast Cancer 3:151–160, 1996.

    Article  PubMed  Google Scholar 

  13. Kajiwara T: Breast-Conserving Therapy: Experience of the Breast Cancer Research Group of Tokyo Women’s Medical College.Breast Cancer 4:1–5, 1997.

    Article  PubMed  Google Scholar 

  14. Karasawa K: Recent Progress in Breast Conserving Therapy: Form a Point of Radiotherapy.Jap J Cancer Clin 46:657–664, 2000 (in Japanese with English abstract).

    Google Scholar 

  15. The Japanese Breast Cancer Society: General Rules for Clinical and Pathological Recording of Breast Cancer, 14th ed, Kanehara Co, Tokyo, pp20–56, 2000.

    Google Scholar 

  16. Harris JR, Levene MB, Svensson G, Hellman S: Analysis of cosmetic results following primary radiation therapy for stage I and II carcinoma of the breast.Int J radiation Oncol Biol Phys 5:257–261, 1979.

    CAS  Google Scholar 

  17. Rubin P, Constine LS 3rd, Fajardo LF, Phillips TL, Wasserman TH: EORTC Late Effects Working Group. Overview of late normal tissues (LENT) scoring system.Radiother Oncol 35:9–10, 1995.

    Article  PubMed  CAS  Google Scholar 

  18. Pavy JJ, Denekamp J, Letschert J, Littbrand B, Mornex F, Bernier J, Gonzales-Gonzales D, Horiot JC, Bolla M, Bartelink H: EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale.Radiother Oncol 35:11–15, 1995.

    Article  PubMed  CAS  Google Scholar 

  19. Renton SC, Gazet JC, Ford HT, Corbishley C, Sutcliffe R: The importance of the resection margin in conservative surgery for breast cancer.Eur J Surg Oncol 22:17–22, 1996.

    Article  PubMed  CAS  Google Scholar 

  20. Anscher MS, Jones P, Prosnitz LR, Blackstock W, Hebert M, Reddick R, Tucker A, Dodge R, Leight G Jr, Iglehart JD: Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy.Ann Surg 218:22–28, 1993

    Article  PubMed  CAS  Google Scholar 

  21. Schnitt SJ, Abner A, Gelman R, Connolly JL, Recht A, Duda RB, Eberlein TJ, Mayzel K, Silver B, Harris JR: The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy.Cancer 74:1746–1751, 1994.

    Article  PubMed  CAS  Google Scholar 

  22. Smitt MC, Nowels KW, Zdeblick MJ, Jeffrey S, Carlson RW, Stockdale FE, Goffinet DR: The importance of the lumpectomy surgical margin status in longterm results of breast conservation.Cancer 76:259–267, 1995.

    Article  PubMed  CAS  Google Scholar 

  23. Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, Silver B, Hetelekidis S, Abner A, Harris JR, Schnitt SJ: Outcome at 8 Years After Breast-Conserving Surgery and Radiation Therapy for Invasive Breast Cancer: Influence of Margin Status and Systemic Therapy on Local Recurrence.J Clinic Oncol 18:1668–1675, 2000.

    CAS  Google Scholar 

  24. Singletary SE: Surgical margins in patients with earlystage breast cancer treated with breast conservation therapy.Am J Surg 184:383–393, 2002.

    Article  PubMed  Google Scholar 

  25. Peterson ME, Schultz DJ, Reynolds C, Solin LJ: Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: The University of Pennsylvania experience.Int J Radiat Oncol Biol Phys 43:1029–1035, 1999.

    Article  PubMed  CAS  Google Scholar 

  26. Wazer DE, Jabro G, Ruthazer R, Schmid C, Safaii H, Schmidt-Ullrich RK: Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation.Radiat Oncol Investig 7:111–117, 1999.

    Article  PubMed  CAS  Google Scholar 

  27. Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JH, Jager JJ, Pierart M, Poortmans PM, Struikmans H, Maat B, Van Limbergen E, Bartelink H: The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC “boost vs no boost” trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups.Radiother Oncol 55:219–232, 2000.

    Article  PubMed  CAS  Google Scholar 

  28. Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, Fourquet A, Borger J, Jager J, Hoogenraad W, Collette L, Pierart M: European Organization for Research and Treatment of Cancer Radiotherapy and Breast Cancer Groups: Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.N Engl J Med 345:1378–1387, 2001.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kumiko Karasawa.

About this article

Cite this article

Karasawa, K., Obara, T., Shimizu, T. et al. Outcome of breast-conserving therapy in the Tokyo women’s medical university breast cancer society experience. Breast Cancer 10, 341–348 (2003). https://doi.org/10.1007/BF02967655

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02967655

Key words

Navigation